investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Genetic components of adverse effects of cisplatin therapy

Peter Demant

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Jeffrey Victor Ravetch

Molecular aspects of antitumor antibodies

Melanoma of skin All cancers but non-melanoma skin cancer

Nikolaos Parisis

A Novel Histone H3 Phosphorylation that Regulates Genome Integrity

All cancers but non-melanoma skin cancer

Robert Blumenthal

Lipid-based Nanocapsules and Triggered Chemotherapy

All cancers but non-melanoma skin cancer

Jill P Mesirov

Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research

All cancers but non-melanoma skin cancer

Eric Freed

Inhibition of HIV-1 Maturation

All cancers but non-melanoma skin cancer

Joseph Barchi

Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines

All cancers but non-melanoma skin cancer

Stuart Le Grice

HIV-1 RNase H as a Therapeutic Target

All cancers but non-melanoma skin cancer

Andrew H Beck

INFORMATICS METHODS AND MODELS FOR COMPUTATIONAL PATHOLOGY

Melanoma of skin All cancers but non-melanoma skin cancer

Xiaomin Bao

Regulators of Epidermal Gene Expression

Melanoma of skin All cancers but non-melanoma skin cancer